| Authors: |
Marvin-Peek J; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kontoyiannis DP; Department of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Adachi J; Department of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ohanian M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kornblau S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. |
